Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Diagnostic Model for Multi-cancer Diagnosis Based on DNA Methylation Biomarkers

NCT05685524 is registered in ClinicalTrials.gov with Wuhan Ammunition Life-tech Co., Ltd as lead sponsor.

NCT NCT05685524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05685524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Diagnostic Model for Multi-cancer Diagnosis Based on DNA Methylation Biomarkers
Lead sponsor
Wuhan Ammunition Life-tech Co., Ltd
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2022
Completion date
December 31, 2023
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer